Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitul Shah

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
Plos One|May 6, 2016
RAD51B in Familial Breast CancerLiisa M Pelttari, Sofia Khan, Mikko Vuorela, et al.
The Journal of Pathology. Clinical Research|August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium studyPeter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
Oncotarget|December 22, 2017
<i>PHIP</i> - a novel candidate breast cancer susceptibility locus on 6q14.1Xiang Jiao, Christos Aravidis, Rajeshwari Marikkannu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Human Molecular Genetics|April 26, 2012
The role of genetic breast cancer susceptibility variants as prognostic factorsPeter A Fasching, Paul D P Pharoah, Angela Cox, et al.
Nature Communications|June 18, 2014
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapyJingmei Li, Linda S Lindström, Jia N Foo, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Plos One|August 25, 2016
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility LocusHisani N Horne, Charles C Chung, Han Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesNicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Plos Medicine|August 24, 2016
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentYan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Plos One|May 6, 2016
RAD51B in Familial Breast CancerLiisa M Pelttari, Sofia Khan, Mikko Vuorela, et al.
The Journal of Pathology. Clinical Research|August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium studyPeter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
Oncotarget|December 22, 2017
<i>PHIP</i> - a novel candidate breast cancer susceptibility locus on 6q14.1Xiang Jiao, Christos Aravidis, Rajeshwari Marikkannu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Human Molecular Genetics|April 26, 2012
The role of genetic breast cancer susceptibility variants as prognostic factorsPeter A Fasching, Paul D P Pharoah, Angela Cox, et al.
Nature Communications|June 18, 2014
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapyJingmei Li, Linda S Lindström, Jia N Foo, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Plos One|August 25, 2016
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility LocusHisani N Horne, Charles C Chung, Han Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesNicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Plos Medicine|August 24, 2016
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentYan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, et al.
Pageof 15